Short answer · Medically reviewed summary · Last updated: 2026-04-07
Morquio Syndrome is caused by a genetic deficiency of specific enzymes required to break down complex sugar molecules called glycosaminoglycans (GAGs), leading to their toxic accumulation in the body's tissues. The Genetic Basis Morquio Syndrome, also known as Mucopolysaccharidosis type IV (MPS IV), is an autosomal recessive disorder. This means a child must inherit one faulty gene copy from each parent to develop the condition.
Morquio Syndrome is caused by a genetic deficiency of specific enzymes required to break down complex sugar molecules called glycosaminoglycans (GAGs), leading to their toxic accumulation in the body's tissues.
Morquio Syndrome, also known as Mucopolysaccharidosis type IV (MPS IV), is an autosomal recessive disorder. This means a child must inherit one faulty gene copy from each parent to develop the condition. The disease is categorized into two types based on the specific enzyme missing: Type A (MPS IVA) involves a mutation in the GALNS gene, while Type B (MPS IVB) involves a mutation in the GLB1 gene. Think of these enzymes as biological "recycling centers"; when they are missing or malfunctioning, the body cannot dismantle GAG chains, which then build up like "cellular trash" in the bones, cartilage, and connective tissues, causing the systemic symptoms characteristic of Morquio Syndrome.
Unlike some conditions, there are no known environmental triggers, infectious agents, or autoimmune mechanisms that cause Morquio Syndrome. It is strictly a metabolic disease rooted in the body’s inability to perform a specific chemical task at the cellular level. While the genetic cause is well-established, current research is focused on the secondary effects of this accumulation, such as how GAG buildup triggers chronic inflammation and cellular stress in the skeletal system.
In the context of Morquio Syndrome, the "cause" is the specific genetic mutation that prevents enzyme production. There are no external "risk factors"—such as diet, lifestyle, or maternal behavior—that influence whether a child develops the disease. The risk is determined entirely by the carrier status of the parents. Ongoing clinical research is currently exploring gene therapy and advanced enzyme replacement strategies to address the root metabolic deficiency, offering hope for more effective management of Morquio Syndrome symptoms.
Medical Disclaimer: This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition.